Sales decline 14.36% to Rs 586.79 crore
Net profit of Glaxosmithkline Pharmaceuticals declined 63.44% to Rs 26.42 crore in the quarter ended June 2017 as against Rs 72.27 crore during the previous quarter ended June 2016. Sales declined 14.36% to Rs 586.79 crore in the quarter ended June 2017 as against Rs 685.21 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales586.79685.21 -14 OPM %3.3513.19 -PBDT33.34114.37 -71 PBT25.82109.00 -76 NP26.4272.27 -63Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
